The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.

SMJ // Article

CME Topic

The Many Facets of Cardiovascular Magnetic Resonance Imaging: Review of Background, Clinical Utility, and Increasing Use in the Community Hospital

Authors: Thomas B. Gore MD, Robert C. Rollings MD, Andrew W. Gore III MS

Abstract

Abstract:Cardiovascular magnetic resonance imaging (CMR or cardiac MRI) has advanced dramatically in the last ten years and has been proven a reliable and flexible method for cardiac diagnosis. Stress perfusion MRI is a new technique that accurately detects coronary heart disease with high sensitivity and specificity. The role of CMR is also increasing for the evaluation of congestive heart failure and cardiomyopathy. Late gadolinium enhancement highlights areas of myocardial scar and helps predict prognosis. CMR usually complements, but does not fully replace, other diagnostic modalities. Careful patient selection is required to ensure safety in the presence of this powerful magnetic field. MRI gives unique tissue characterization without ionizing radiation. No longer used just for esoteric conditions, CMR is becoming common in the community hospital.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

References1. Kanal E, Barkovich AJ, Bell C, et al. ACR guidance document for safe MR practices: 2007. AJR Am J Roentgenol 2007;188:1447–1474.KanalE]]BarkovichAJ]]BellC&etal;ACR guidance document for safe MR practices: 2007.AJR Am J Roentgenol20071881447-14742. Levine GN, Gomes AS, Arai AE, et al; American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Radiology and Intervention. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation 2007;116:2878–2891.LevineGN]]GomesAS]]AraiAE&etal;American Heart Association Committee on Diagnostic and Interventional Cardiac CatheterizationAmerican Heart Association Council on Clinical CardiologyAmerican Heart Association Council on Cardiovascular Radiology and InterventionSafety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance.Circulation20071162878-28913. Nazarian S, Roguin A, Zviman MM, et al. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable cardioverter-defibrillators at 1.5 tesla. Circulation 2006;114:1277–1284.NazarianS]]RoguinA]]ZvimanMM&etal;Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable cardioverter-defibrillators at 1.5 tesla.Circulation20061141277-12844. Sommer T, Naehle CP, Yang A, et al. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker dependent patients: a prospective study with 115 examinations. Circulation 2006;114:1285–1292.SommerT]]NaehleCP]]YangA&etal;Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker dependent patients: a prospective study with 115 examinations.Circulation20061141285-12925. Faris OP, Shein M. Food and Drug Administration perspective: magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillator patients. Circulation 2006;114:1232–1233.FarisOP]]SheinMFood and Drug Administration perspective: magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillator patients.Circulation20061141232-12336. Pennell DJ, Sechtem UP, Higgins CB, et al; Society for Cardiovascular Magnetic Resonance; Working Group on Cardiovascular Magnetic Resonance of the European Society of Cardiology. Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. Eur Heart J 2004;25:1940–1965.PennellDJ]]SechtemUP]]HigginsCB&etal;Society for Cardiovascular Magnetic ResonanceWorking Group on Cardiovascular Magnetic Resonance of the European Society of CardiologyClinical indications for cardiovascular magnetic resonance (CMR): consensus panel report.Eur Heart J2004251940-19657. Hendel RC, Patel MR, Kramer CM, et al; American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group; American College of Radiology; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance; American Society of Nuclear Cardiology; North American Society for Cardiac Imaging; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol 2006;48:1475–1497.HendelRC]]PatelMR]]KramerCM&etal;American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working GroupAmerican College of RadiologySociety of Cardiovascular Computed TomographySociety for Cardiovascular Magnetic ResonanceAmerican Society of Nuclear CardiologyNorth American Society for Cardiac ImagingSociety for Cardiovascular Angiography and InterventionsSociety of Interventional RadiologyACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology.J Am Coll Cardiol2006481475-14978. Klem I, Greulich S, Heitner JF, et al. Value of cardiovascular magnetic resonance stress perfusion testing for the detection of coronary artery disease in women. J Am Coll Cardiol Imaging 2008;1:436–445.KlemI]]GreulichS]]HeitnerJF&etal;Value of cardiovascular magnetic resonance stress perfusion testing for the detection of coronary artery disease in women.J Am Coll Cardiol Imaging20081436-4459. Klem I, Heitner JF, Shah DJ, et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol 2006;47:1630–1638.KlemI]]HeitnerJF]]ShahDJ&etal;Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging.J Am Coll Cardiol2006471630-163810. Schwitter J, Wacker CM, van Rossum AC, et al. MR-IMPACT: comparison of perfusion cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 2008;29:480–489.SchwitterJ]]WackerCM]]van RossumAC&etal;MR-IMPACT: comparison of perfusion cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial.Eur Heart J200829480-48911. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992–2002.KimRJ]]FienoDS]]ParrishTB&etal;Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.Circulation19991001992-200212. Vogel-Claussen J, Rochitte CE, Wu KC, et al. Delayed enhancement MR imaging: utility in myocardial assessment. Radiographics 2006;26:795–810.Vogel-ClaussenJ]]RochitteCE]]WuKC&etal;Delayed enhancement MR imaging: utility in myocardial assessment.Radiographics200626795-81013. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445–1453.KimRJ]]WuE]]RafaelA&etal;The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.N Engl J Med20003431445-145314. Nazarian S, Bluemke DA, Lardo AC, et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 2005;112:2821–2825.NazarianS]]BluemkeDA]]LardoAC&etal;Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy.Circulation20051122821-282515. Wu KC, Weiss RG, Thiemann DR, et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in non-ischemic cardiomyopathy. J Am Coll Cardiol 2008;51:2414–2421.WuKC]]WeissRG]]ThiemannDR&etal;Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in non-ischemic cardiomyopathy.J Am Coll Cardiol2008512414-242116. Mollet NR, Dymarkowski S, Volders W, et al. Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease. Circulation 2002;106:2873–2876.MolletNR]]DymarkowskiS]]VoldersW&etal;Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease.Circulation20021062873-287617. Weinsaft JW, Kim HW, Shah DJ, et al. Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance: prevalence and markers in patients with systolic dysfunction. J Am Coll Cardiol 2008;52:148–157.WeinsaftJW]]KimHW]]ShahDJ&etal;Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance: prevalence and markers in patients with systolic dysfunction.J Am Coll Cardiol200852148-15718. Atar et al. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Results of the FIRE (efficacy of FX06 in the prevention of myocardial reperfusion injury) trial. J Am Coll Cardiol In press.19. Kuo PH, Kanal E, Abu-Alfa AK, et al. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 2007;242:647–649.KuoPH]]KanalE]]Abu-AlfaAK&etal;Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis.Radiology2007242647-64920. Halvorsen RA. Which study when? Iodinated contrast-enhanced CT versus gadolinium-enhanced MR imaging. Radiology 2008;249:9–15.HalvorsenRAWhich study when? Iodinated contrast-enhanced CT versus gadolinium-enhanced MR imaging.Radiology20082499-1521. Juluru K, Vogel-Claussen J, Macura KJ, et al. MR Imaging in patients at risk for developing nephrogenic systemic fibrosis: protocols, practices, and imaging techniques to maximize patient safety. Radiographics 2009;29:9–22.JuluruK]]Vogel-ClaussenJ]]MacuraKJ&etal;MR Imaging in patients at risk for developing nephrogenic systemic fibrosis: protocols, practices, and imaging techniques to maximize patient safety.Radiographics2009299-22